. 2023 Mar 12;24(6):5436. doi: 10.3390/ijms24065436

Table 1.

Abnormally expressed miRNAs in acute lymphoblastic leukemia patients compared to healthy individuals.

Upregulated	Downregulated
miR-7e [111], miR-9 [111], miR-9* [111], miR-34a [116], miR-92a [113], miR-100 [119], miR-125b-1 [114], miR-128 [111,120,121], miR-130b [111], miR-142-3p [112], miR-146a [115,119,122], miR-155 [115], miR-181 [121], miR-181a [111,117], miR-181b [111,115], miR-210 [123], miR-222 [112,116], miR-339 [112], miR-363 [111], miR-511 [116], miR-638 [113], miR-1943 [111], miR-1841 [111], miR-1931 [111], miR-1987 [111], miR-1890 [111], miR-1902 [111]	let-7e [121], miR-18a [124], miR-26a [116], miR-30a [111], miR-100 [121,123], miR-126 [111], miR-143 [111], miR-145 [115], miR-196a [119], miR-196b [117,121], miR-199b-3p [111], miR-200c [125], miR-203 [114], miR-221 [116], miR-223 [111,116], miR-326 [125], miR-373* [112], miR-451 [112], miR-582-5p [111], miR-1893 [111], miR-1971* [111], miR-1834 [111], miR-1842* [111], miR-1842 [111]

Upregulated

Downregulated

miR-7e [111], miR-9 [111], miR-9* [111], miR-34a [116], miR-92a [113], miR-100 [119], miR-125b-1 [114], miR-128 [111,120,121], miR-130b [111], miR-142-3p [112], miR-146a [115,119,122], miR-155 [115], miR-181 [121], miR-181a [111,117], miR-181b [111,115], miR-210 [123], miR-222 [112,116], miR-339 [112], miR-363 [111], miR-511 [116], miR-638 [113], miR-1943 [111], miR-1841 [111], miR-1931 [111], miR-1987 [111], miR-1890 [111], miR-1902 [111]

let-7e [121], miR-18a [124], miR-26a [116], miR-30a [111], miR-100 [121,123], miR-126 [111], miR-143 [111], miR-145 [115], miR-196a [119], miR-196b [117,121], miR-199b-3p [111], miR-200c [125], miR-203 [114], miR-221 [116], miR-223 [111,116], miR-326 [125], miR-373* [112], miR-451 [112], miR-582-5p [111], miR-1893 [111], miR-1971* [111], miR-1834 [111], miR-1842* [111], miR-1842 [111]

MiRNAs in bold letters are described in more than one paper.